Related references
Note: Only part of the references are listed.Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
Maria Eugenia Miquilena-Colina et al.
GUT (2011)
Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk
A. Handberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Fatty acid transport across the cell membrane: Regulation by fatty acid transporters
Robert W. Schwenk et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice
Jennifer J. Manning-Tobin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36
R. L. SILVERSTEIN
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men
Aase Handberg et al.
DIABETES & VASCULAR DISEASE RESEARCH (2009)
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study
Susanne R. de Rooij et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Anna Kotronen et al.
GASTROENTEROLOGY (2009)
Fatty Liver Is Associated with Insulin Resistance, Risk of Coronary Heart Disease, and Early Atherosclerosis in a Large European Population
Amalia Gastaldelli et al.
HEPATOLOGY (2009)
Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance
Jose-Manuel Fernandez-Real et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Cellular fatty acid uptake: a pathway under construction
Xiong Su et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Gene expression in human NAFLD
Dario Greco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Fatty liver - A novel component of the metabolic syndrome
Anna Kotronen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Molecular Mechanisms of Atherosclerosis in Metabolic Syndrome Role of Reduced IRS2-Dependent Signaling
Herminia Gonzalez-Navarro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
Latisha Love-Gregory et al.
HUMAN MOLECULAR GENETICS (2008)
CD36 Is Significantly Correlated with Adipophilin in Human Carotid Lesions and Inversely Correlated with Plasma ApoAI
Sophie Collot-Teixeira et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2008)
Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability
Aase Handberg et al.
STROKE (2008)
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Dorte Glintborg et al.
DIABETES CARE (2008)
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity
Debby P. Y. Koonen et al.
DIABETES (2007)
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Eugene A. Podrez et al.
NATURE MEDICINE (2007)
Insulin resistance, insulin response, and obesity as indicators of metabolic risk
Ele Ferrannini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
CD36 and macrophages in atherosclerosis
Sophie Collot-Teixeira et al.
CARDIOVASCULAR RESEARCH (2007)
Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients
Shizuya Yamashita et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma - A novel marker of insulin resistance
Aase Handberg et al.
CIRCULATION (2006)
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives
SA Hills et al.
DIABETOLOGIA (2004)
Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis
M Febbraio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Genetic study of the CD36 gene In a French diabetic population
F Leprêtre et al.
DIABETES & METABOLISM (2004)
CD36 deficiency and insulin resistance
JR Petrie et al.
LANCET (2001)
CD36 deficiency associated with insulin resistance
K Miyaoka et al.
LANCET (2001)
Share Paper
